Skip to content

Management of Patients with Pancreatic Malignancies-A Cohort Study

Management of Patients with Pancreatic Malignancies-A Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071581
Enrollment
Unknown
Registered
2023-05-18
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Malignancies

Interventions

Pancreatic Malignancies:Observational study, no intervention

Sponsors

Chengdu Seventh People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Age =18 years old; ? Patients with pathologically or clinically confirmed pancreatic malignant tumors; ? Patients can understand the content of this study and have the ability to follow up the study plan, sign the informed consent and volunteer to participate in this study. Patients who meet the above three criteria were eligible for inclusion in this study.

Exclusion criteria

Exclusion criteria: ? Age < 18 years old; ? Benign tumor was confirmed by pathology; ? The patient have cognitive impairment; ? Patients who were unable to understand or comply with the study procedures and signed written informed consent. Patients who meet one of the above three criteria were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Overall survival;

Secondary

MeasureTime frame
patient reported outcomes;progression free survival;objective remission rate;Disease control rate;Treatment schedule change time;Equivalent morphine dose;Use of antiemetic drugs;Activity tolerance;

Countries

China

Contacts

Public ContactPing Chen

Chengdu Seventh People’s Hospital

chenpingab@163.com+86 13408413192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026